Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm protein associated with the nucleus on the X chromosome N2 (SPANXN2) is a member of the SPANX (Sperm Protein Associated with the Nucleus on the X chromosome) family of cancer/testis antigens. It belongs to the SPANX-N subfamily, which is characterized by its exclusive expression in normal testis and restricted expression in certain malignancies such as melanoma and testicular germ cell tumors (TGCTs)[6][7][4]. SPANXN2 is a small, largely disordered nuclear protein containing conserved hydrophobic and nuclear localization motifs[1]. Functionally, SPANXN2 inhibits cell migration and colony formation in testicular germ cell tumor models, likely through the regulation of EMT (epithelial-mesenchymal transition) and AKT signaling pathway components, including downregulation of vimentin, Snail, and AKT/p-AKT proteins[2][4]. Loss or downregulation of SPANXN2 is associated with increased cell motility and metastatic potential in TGCTs, suggesting a tumor suppressor-like role in this context[2][4]. While SPANX family proteins are implicated in chromatin organization and nuclear structure in spermatozoa, the specific molecular partners and functions of SPANXN2 remain to be elucidated[1][3][6][7]. No drugs directly targeting SPANXN2 are reported, and no mechanism of action for such drugs is known. As a highly tissue-restricted (testis-specific) cancer/testis antigen, SPANXN2 may serve as a biomarker for TGCT prognosis or therapy, though its clinical utility and safety profile are currently underexplored[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm protein associated with the nucleus on the X chromosome N2 (SPANXN2).